1xbet 우회., Ltd.

1xbet 우회., Ltd. (Otsuka) and Denka Company, Limited (Denka) announce that on June 16, Denka received manufacturing and marketing approval in Japan for Quick Navi ™ -Flu + COVID-19 Ag. This antigen rapid diagnostic kit enables medical professionals to simultaneously diagnose influenza and Covid-19. It is the latest product in the QuickNavi^TMseries of in vitro diagnostics. The combo kit is to be manufactured in Japan by Denka and will be co-marketed in the country by Denka and 1xbet 우회.

In the past, it was necessary to test separately 1xbet 우회 the Covid-19 and influenza, but with this combination kit, the burdens of sample-taking, the time required 1xbet 우회 sample assessment, and the wait-time 1xbet 우회 review by a medical professional can be reduced.

This combination diagnosis kit reduces from a total of 15 minutes to a total of 10 minutes the assessment time 1xbet 우회 the presence or absence of a specific Covid-19 antigen.